Bill Text: US HB3839 | 2023-2024 | 118th Congress | Introduced


Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Sponsorship: Bipartisan Bill

Status: (Introduced - Dead) 2023-06-09 - Referred to the Subcommittee on Health. [HB3839 Detail]

Download: US_Congress-2023-HB3839-Introduced.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.
feedback